Press Releases 2013
Press Releases 2012
Press Releases 2011
Press Releases 2010
Press Releases 2009
Press Releases 2008
Press Releases 2007
Press Releases 2006
Press Releases 2005
Press Releases 2004
Press Releases 2003
11.20.09
Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering
11.10.09
Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide
11.02.09
Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in Patients with Chronic Constipation
- Top-line Results Show Each Trial Met Primary and All Secondary Endpoints
10.27.09
Marsha Fanucci Joins Ironwood Board of Directors
- Former Millennium CFO
09.14.09
Ironwood Appoints Thomas Mccourt as Chief Commercial Officer and Senior Vice President of
Marketing And Sales.
09.14.09
David Ebersman Joins Ironwood Board of Directors
- Facebook CFO and Former Genentech CFO
05.31.09
Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome with Constipation -
Data Presented Today at DDW Demonstrate Linaclotide Provided Early Onset of Abdominal Pain Relief and Improved Bowel Habits
05.12.09
Ironwood and Forest to Present Additional Phase 2b Data for Novel Gastrointestinal Agent Linaclotide
- Data to be Presented at Digestive Disease Week 2009
05.04.09
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
- Ironwood Will Receive Up To $55 Million in Near Term Payments
Lisa Buffington
VP, Corporate Communications
617.374.5103
lbuffington@ironwoodpharma.com
Copyright © 2013, Ironwood Pharmaceuticals, Inc.
All Rights Reserved
|
Privacy Policy
|
Terms of Service
|
Site Design
